Biotech & Pharmaceutical Business Plan
Life science business plans built by senior consultants with deep biotech and pharma experience.
Capital West Advisors is one of the most experienced life science planning firms in the U.S. and is extremely experienced with life science companies. CWA has 4 staff members with life science business planning experience. Seth Schwartz previously worked at the Kriegsman Group, which specialized in procuring investment capital for life science companies. CWA develops world-class life science business plans across pharmaceuticals, biotechnology, medical devices, and medical supplies, and numerous CWA life science clients have secured capital.
What's included
- Product development plan with FDA clinical trial stages passed and pending
- Technical product / compound / technology description
- Competing Technologies section comparing similar technologies
- Disease-specific market analysis and statistics
- Detailed R&D, equipment, and salary cost projections
- Appendix with clinical trial data and/or IP
- Funding request and use of proceeds
- Investor-ready financial model
CWA's experience
CWA has 4 staff members with life science business planning experience. Seth Schwartz previously worked at the Kriegsman Group, which specialized in procuring investment capital for life science companies. CWA is highly experienced across pharmaceuticals, biotechnology, medical devices, and medical supplies, and numerous CWA life science clients have secured capital.
Unique elements of a biotech & pharmaceutical business plan
A biotechnology or pharmaceutical business plan should closely detail the development plan of the product(s) and the several stages of FDA clinical trials that each product has already passed and/or still needs to conduct and pass. The product (or technology) section should provide a strong technical description of the product, compound, or technology being developed and should often contain a Competing Technologies section, which technically describes similar and competing technologies. The market section should focus on the specific market for that category of drug, device, or compound and include statistics regarding the various diseases the business will treat. The financial plan should closely detail the projected costs of research, development, equipment, and salaries the business will incur to bring the product to market and beyond.
Length and pricing
A biotech or pharmaceutical business plan is typically approximately 25 to 35 pages in length and can contain an Appendix with data from clinical trials and/or intellectual property pertaining to the product. Biotechnology and pharmaceutical business plans typically range from $3,000 to $5,500 to develop a full business plan.
Get a free quote for your biotech & pharmaceutical business plan
Talk to a senior consultant. We'll scope your project and send a competitive quote within 24 hours.